Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: Antitachycardia pacing therapy during charging

Heart Rhythm

Volumn 4, Issue 7, 2007, Pages 879-885

  Schoels, Wolfgang ^a   Steinhaus, David ^b   Johnson, W Ben ^c   O'Hara, Gilles ^d   Schwab, Joerg O ^e   Jenniskens, Inge ^f   DeGroot, Paul J ^b   Tang, Feng ^b   Helmling, Erhard ^g  

^a Evangelisches und Johanniter Klinikum Niederrhein   (Germany)

^b MEDTRONIC INC   (United States)

^c IOWA HEART CENTER   (United States)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITY OF BONN   (Germany)

^f MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^g Westpfalz Klinikum GmbH   (Germany)

Author keywords

Antitachycardia pacing; Defibrillation; Implantable Cardioverter Defibrillator; Implantable Defibrillator; Ventricular Fibrillation; Ventricular Tachycardia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DEFIBRILLATOR; FEMALE; HEART PACING; HEART RHYTHM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOMORPHIC VENTRICULAR TACHYCARDIA; PATIENT SAFETY; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; SHOCK; SYMPTOM; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 34250745334     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.03.008     Document Type: Article

References (17)

1. Wilkoff B.L., Ousdigian K.T., Sterns L.D., Wang Z.J., Wilson R.D., and Morgan J.M. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 48 (2006) 330-339
2. Wathen M., DeGroot P., Sweeney M., Stark A.J., Otterness M.F., Adkisson W.O., Canby R.C., Khalighi K., Machado C., Rubenstein D.S., Volosin K.J., and PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shock for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter defibrillators. Circulation 110 (2004) 2591-2596
3. Wathen M., Sweeney M., DeGroot P., Start A., Koehler J., Chisner M., Machado C., Adkisson W., and PainFREE Rx Investigators. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 104 (2001) 796-801
4. Schaumann A., von zur Muhlen F., Herse B., Gonska B., and Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation 97 (1998) 66-74
5. Farmer D.M., Swygman C.A., Wang P.J., Mark Estes N.A., and Link M.S. Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators). Am J Cardiol 91 (2003) 606-609
6. Windecker S., Ideker R.E., Plumb V.J., Kay G.N., Walcott G.P., and Epstein A.E. The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans. J Am Coll Cardiol 33 (1999) 33-38
7. Gradaus R., Bode-Schnurbus L., Weber M., Rotker J., Hammel D., Breithardt G., and Bocker D. Effect of ventricular fibrillation duration on the defibrillation threshold in humans. Pacing Clin Electrophysiol 25 (2002) 14-19
8. Gregoratos G., Abrams J., Epstein A., Freedman R., Hayes D., Hlatky M., Kerber R., Naccarelli G., Schoenfeld M., Silka M., and Winters S. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). Circulation 106 (2002) 2145-2161
9. Congdon P. Bayesian statistical modeling. 1st ed. (2003), Wiley, New York
10. Cochran W. Sampling techniques. 3d ed. (1977), John Wiley and Sons, New York
11. Liang K.Y., and Zeger S.L. Longitudinal analysis using generalized linear models. Biometrics 35 (1986) 795-802
12. Irvine J., Dorain P., Baker B., O'Brien B.J., Roberts R., Gent M., Newman D., and Connolly S.J. Quality of life in the Canadian Implantable Defibrillator Study. Am Heart J 144 (2002) 282-289
13. Schron E.B., Exner D.V., Yao Q., Jenkins L.S., Steinberg J.S., Cook J.R., Kutalek S.P., Friedman P.L., Bubien R.S., Page R.L., and Powell J. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 (2002) 589-594
14. Sharma V., DeGroot P.J., and Wathen M.S. Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients. J Cardiovasc Electrophysiol 14 (2003) 1156-1162
15. Monahan K.M., Hadjis T., Hallett N., Casavant D., and Josephson M.E. Relation of induced to spontaneous ventricular tachycardia from analysis of stored far-field implantable defibrillator electrograms. Am J Cardiol 83 (1999) 349-353
16. Porterfield J.G., Porterfield L.M., Smith B.A., Bray L., Voshage L., Martinez A., and Ventak PRx Phase I Investigators. Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. Pacing Card Electrophysiol 16 (1993) 170-173
17. Kouakam C., Lauwerier B., Klug D., Jarwe M., Marquie C., Lacroix D., and Kacet S. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators. Am J Cardiol 92 (2003) 26-32